Verve Therapeutics, Inc. (NASDAQ:VERV) Given Average Recommendation of Moderate Buy by Brokerages

Shares of Verve Therapeutics, Inc. (NASDAQ:VERV – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the eight brokerages that are presently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month price […]

Related Keywords

Canada ,United States ,Stifel Nicolaus ,Royal Bank ,Nasdaq ,Newbridge Financial Services Group Inc ,Quest Partners ,Daiwa Securities Group Inc ,Financial Services Group Inc ,Verve Therapeutics Inc ,Verve Therapeutics ,Get Free Report ,Services Group ,Financial Services Group ,Securities Group ,Get Free ,Verve Therapeutics Daily ,